FindTrial
Sign In

Evaluation on early onset sepsis (EOS) prediction and risk management programme for high risk neonates

Evaluation on early onset sepsis (EOS) prediction and risk management programme for high risk neonates

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000037015
Enrollment
Unknown
Registered
2020-08-26
Start date
2020-10-01
Completion date
Unknown
Last updated
2020-09-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Early Onset Sepsis, EOS

Interventions

Gold Standard:Blood plate culture and 16sRNA/ metagenomic sequencing of blood microorganism
Index test:Precise&#32
prediction&#32
model&#32
for&#32
EOS&#32
in&#32
neonates&#32
with&#32
high&#32
risk&#32
of&#32
perinatal&#32
infection

Sponsors

International Peace Maternity and Child Health Hospital, International Peace China welfare Institute, School of Medicine, Shanghai Jiao Tong University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Neonates without EOS symptoms and with high risk of perinatal infection within 7 days of birth based on EOS risk model assessment including 15 prenatal factors

Exclusion criteria

Exclusion criteria: Nil

Design outcomes

Primary

MeasureTime frame
Incidence of premature sepsis (EOS) in newborns within 7 days of birth;—

Secondary

MeasureTime frame
Rate of neonatal exclusion of premature sepsis (EOS) without prophylactic antibiotics;—

Countries

China

Contacts

Public ContactZhiwei Liu

International Peace Maternity and Child Health Hospital, International Peace China welfare Institute, School of Medicine, Shanghai Jiao Tong University

liuzhiwei@hotmail.com+86 18017316005

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026